An investigational anticoagulant that targets factor XI failed to prevent arteriovenous graft (AVG) thrombosis in chronic hemodialysis patients, according to a placebo-controlled phase IIb trial. In ...
All chronic HD patients dialyzed for more than 3 months (in three 4-h sessions per week) between 1986 and 2005 at the China Medical University Hospital were reviewed. A total of 576 patients dialyzed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results